Optimising the IgG‐degrading enzyme treatment regimen for enhanced adeno‐associated virus transduction in the presence of neutralising antibodiesIrene Ros‐Gañán, Gloria González‐Aseguinolaza|Clinical & Translational Immunology|2022Cited by 32